SEC Form D · filed April 8, 2021
Revel Pharmaceuticals Inc
Offering
$1.6M
Sold
$800K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (5)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗